Abstract:Hepatitis B virus (HBV) carrying the rtA181T/sW172* mutation conferred cross-resistance to adefovir and lamivudine. Cell-based and clinical studies indicated that HBV carrying this mutation had an increased oncogenic potential. Herein, we created transgenic mouse models to study the oncogenicity of the HBV pre-S/S gene containing this mutation. Transgenic mice were generated by transfer of the HBV pre-S/S gene together with its own promoter into C57B6 mice. Four lines of mice were created. Two of them carried wild-type gene and produced high and low levels of HBV surface antigen (HBsAg) (TgWT-H and L). The other two carried the sW172* mutation with high and low intrahepatic expression levels (TgSW172*-H and L). When sacrificed 18 months after birth, none of the TgWT mice developed hepatocellular carcinoma (HCC), whereas 6/26 (23.1%) TgSW172*-H and 2/24 (8.3%) TgSW172*-L mice developed HCC (TgWT vs TgSW172*; P=0.0021). Molecular analysis of liver tissues revealed significantly increased expression of glucose-regulated protein 78 and phosphorylated extracellular signal-regulated kinases 1 in TgSW172* mice, and decreased expression of B-cell lymphoma-extra large in TgSW172*-H mice. Higher proportion of apoptotic cells was found in TgSW172*-H mice, accompanied by increased cyclin E levels, suggesting increased hepatocyte turnover. Combined analysis of complimentary DNA microarray and microRNA array identified microRNA-873-mediated reduced expression of the CUB and Sushi multiple domains 3 (CSMD3) protein, a putative tumor suppressor, in TgSW172* mice. Our transgenic mice experiments confirmed that HBV pre-S/S gene carrying the sW172* mutation had an increased oncogenic potential. Increased endoplasmic reticulum stress response, more rapid hepatocyte turnover and decreased CSMD3 expression contributed to the hepatocarcinogenesis.

CRISPR/Cas9-mediated P53 and Pten Dual Mutation Accelerates Hepatocarcinogenesis in Adult Hepatitis B Virus Transgenic Mice

CRISPR-mediated Direct Mutation of Cancer Genes in the Mouse Liver.

CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse

Hbs4g And Hbx Knocked Into The P21 Locus Causes Hepatocellular Carcinoma In Mice

Overexpression of HMGB1 in Hepatocytes Accelerates PTEN Inactivation-Induced Liver Cancer

Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice

Observation on Experimental Liver Fibrosis and Hepatic Carcinogenesis of HBV Gene Knock-in Transgenic Mice Induced by CCl_4/ethanol

Cooperation between liver-specific mutations of pten and tp53 genetically induces hepatocarcinogenesis in zebrafish

Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns

Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation

The Mutational and Transcriptional Landscapes of Hepatocarcinogenesis in a Rat Model

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging

Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy

HBx Gene Inducing Hepatocellular Carcinoma in Vivo and Its Mechanism

CRISPR/Cas9-mediated Knockout of HBsAg Inhibits Proliferation and Tumorigenicity of HBV-positive Hepatocellular Carcinoma Cells

Truncated Hbx-Dependent Silencing of Gas2 Promotes Hepatocarcinogenesis Through Deregulation of Cell Cycle, Senescence and P53-Mediated Apoptosis

Transgenic Mice Expressing Hepatitis B Virus X Protein Are More Susceptible to Carcinogen Induced Hepatocarcinogenesis.

Effects of Hepatitis B Virus on P53 Expression in Hepatoma Cell Line SMMU-7721

Accelerated Hepatocellular Carcinoma Development in Mice Expressing the Pim-3 Transgene Selectively in the Liver.

Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice

Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice